Icosavax Inc (DELISTED) (ICVX:DL)
15.31
0.00 (0.00%)
USD |
NASDAQ |
Feb 29, 16:00
Icosavax Cash from Operations (TTM): -71.48M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -71.48M |
| June 30, 2023 | -69.88M |
| March 31, 2023 | -65.86M |
| December 31, 2022 | -61.68M |
| September 30, 2022 | -63.08M |
| June 30, 2022 | -55.03M |
| Date | Value |
|---|---|
| March 31, 2022 | -51.82M |
| December 31, 2021 | -38.54M |
| September 30, 2021 | -29.19M |
| June 30, 2021 | -22.30M |
| March 31, 2021 | -14.85M |
| December 31, 2020 | -14.21M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-71.48M
Minimum
Sep 2023
-14.21M
Maximum
Dec 2020
-46.49M
Average
-53.42M
Median
Cash from Operations (TTM) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | -385.82M |
| Immunogen Inc (DELISTED) | -197.89M |
| AbbVie Inc | 22.69B |
| Assure Holdings Corp | -5.044M |
| Harpoon Therapeutics Inc (DELISTED) | -69.38M |